Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

Stem cell factor is a novel independent prognostic biomarker for hepatocellular carcinoma after curative resection.

Wang X, Ren H, Zhao T, Chen J, Sun W, Sun Y, Ma W, Wang J, Gao C, Gao S, Lang M, Jia L, Hao J.

Carcinogenesis. 2014 Oct;35(10):2283-90. doi: 10.1093/carcin/bgu162. Epub 2014 Aug 2.

PMID:
25086759
2.

Expression and prognostic significance of vascular endothelial growth factor receptor 1 in hepatocellular carcinoma.

Li T, Zhu Y, Qin CY, Yang Z, Fang A, Xu S, Ren W.

J Clin Pathol. 2012 Sep;65(9):808-14. doi: 10.1136/jclinpath-2012-200721. Epub 2012 Jun 25.

PMID:
22734007
3.

The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection.

Chen D, Xing W, Hong J, Wang M, Huang Y, Zhu C, Yuan Y, Zeng W.

Ann Surg Oncol. 2012 Oct;19(11):3556-65. doi: 10.1245/s10434-012-2396-1. Epub 2012 May 17.

PMID:
22588469
4.

The prognostic significance of vasohibin 1-associated angiogenesis in patients with hepatocellular carcinoma.

Murakami K, Kasajima A, Kawagishi N, Sekiguchi S, Fujishima F, Watanabe M, Sato Y, Ohuchi N, Sasano H.

Hum Pathol. 2014 Mar;45(3):589-97. doi: 10.1016/j.humpath.2013.10.028. Epub 2013 Nov 6.

PMID:
24444468
5.

CD147, MMP-2, MMP-9 and MVD-CD34 are significant predictors of recurrence after liver transplantation in hepatocellular carcinoma patients.

Zhang Q, Chen X, Zhou J, Zhang L, Zhao Q, Chen G, Xu J, Qian F, Chen Z.

Cancer Biol Ther. 2006 Jul;5(7):808-14. Epub 2006 Jul 30.

PMID:
16775432
6.

High expression levels of putative hepatic stem/progenitor cell biomarkers related to tumour angiogenesis and poor prognosis of hepatocellular carcinoma.

Yang XR, Xu Y, Yu B, Zhou J, Qiu SJ, Shi GM, Zhang BH, Wu WZ, Shi YH, Wu B, Yang GH, Ji Y, Fan J.

Gut. 2010 Jul;59(7):953-62. doi: 10.1136/gut.2008.176271. Epub 2010 May 4.

PMID:
20442200
7.

High-level expression of HOXB13 is closely associated with tumor angiogenesis and poor prognosis of hepatocellular carcinoma.

Zhu JY, Sun QK, Wang W, Jia WD.

Int J Clin Exp Pathol. 2014 May 15;7(6):2925-33. eCollection 2014.

8.

High preoparative levels of serum periostin are associated with poor prognosis in patients with hepatocellular carcinoma after hepatectomy.

Lv Y, Wang W, Jia WD, Sun QK, Huang M, Zhou HC, Xia HH, Liu WB, Chen H, Sun SN, Xu GL.

Eur J Surg Oncol. 2013 Oct;39(10):1129-35. doi: 10.1016/j.ejso.2013.06.023. Epub 2013 Jul 31.

PMID:
23916473
9.

Intratumoral α-SMA enhances the prognostic potency of CD34 associated with maintenance of microvessel integrity in hepatocellular carcinoma and pancreatic cancer.

Wang WQ, Liu L, Xu HX, Luo GP, Chen T, Wu CT, Xu YF, Xu J, Liu C, Zhang B, Long J, Tang ZY, Yu XJ.

PLoS One. 2013 Aug 5;8(8):e71189. doi: 10.1371/journal.pone.0071189. Print 2013.

10.

Intratumoral neutrophils: a poor prognostic factor for hepatocellular carcinoma following resection.

Li YW, Qiu SJ, Fan J, Zhou J, Gao Q, Xiao YS, Xu YF.

J Hepatol. 2011 Mar;54(3):497-505. doi: 10.1016/j.jhep.2010.07.044. Epub 2010 Oct 1.

PMID:
21112656
11.

SUOX is a promising diagnostic and prognostic biomarker for hepatocellular carcinoma.

Jin GZ, Yu WL, Dong H, Zhou WP, Gu YJ, Yu H, Yu H, Lu XY, Xian ZH, Liu YK, Cong WM, Wu MC.

J Hepatol. 2013 Sep;59(3):510-7. doi: 10.1016/j.jhep.2013.04.028. Epub 2013 May 9.

PMID:
23665285
12.

Expression features of SOX9 associate with tumor progression and poor prognosis of hepatocellular carcinoma.

Guo X, Xiong L, Sun T, Peng R, Zou L, Zhu H, Zhang J, Li H, Zhao J.

Diagn Pathol. 2012 Apr 19;7:44. doi: 10.1186/1746-1596-7-44.

13.

Cytokeratin 10 and cytokeratin 19: predictive markers for poor prognosis in hepatocellular carcinoma patients after curative resection.

Yang XR, Xu Y, Shi GM, Fan J, Zhou J, Ji Y, Sun HC, Qiu SJ, Yu B, Gao Q, He YZ, Qin WZ, Chen RX, Yang GH, Wu B, Lu Q, Wu ZQ, Tang ZY.

Clin Cancer Res. 2008 Jun 15;14(12):3850-9. doi: 10.1158/1078-0432.CCR-07-4338.

14.

MicroRNA-224 upregulation and AKT activation synergistically predict poor prognosis in patients with hepatocellular carcinoma.

Yu L, Zhang J, Guo X, Li Z, Zhang P.

Cancer Epidemiol. 2014 Aug;38(4):408-13. doi: 10.1016/j.canep.2014.05.001. Epub 2014 Jun 10.

PMID:
24923856
15.

Peritumoral ductular reaction: a poor postoperative prognostic factor for hepatocellular carcinoma.

Xu M, Xie F, Qian G, Jing Y, Zhang S, Gao L, Zheng T, Wu M, Yang J, Wei L.

BMC Cancer. 2014 Feb 5;14:65. doi: 10.1186/1471-2407-14-65.

16.

Aberrant expression of monocarboxylate transporter 4 in tumour cells predicts an unfavourable outcome in patients with hepatocellular carcinoma.

Ohno A, Yorita K, Haruyama Y, Kondo K, Kato A, Ohtomo T, Kawaguchi M, Marutuska K, Chijiiwa K, Kataoka H.

Liver Int. 2014 Jul;34(6):942-52. doi: 10.1111/liv.12466. Epub 2014 Feb 7.

PMID:
24433439
17.

Thymidine phosphorylase (platelet-derived endothelial cell growth factor), microvessel density and clinical outcome in hepatocellular carcinoma.

Yamamoto A, Dhar DK, El-Assal ON, Igarashi M, Tabara H, Nagasue N.

J Hepatol. 1998 Aug;29(2):290-9.

PMID:
9722211
18.

Smad3 and its phosphoisoforms are prognostic predictors of hepatocellular carcinoma after curative hepatectomy.

Kim SH, Ahn S, Park CK.

Hepatobiliary Pancreat Dis Int. 2012 Feb;11(1):51-9.

PMID:
22251470
19.

The significance of MMP-9 over MMP-2 in HCC invasiveness and recurrence of hepatocellular carcinoma after curative resection.

Chen R, Cui J, Xu C, Xue T, Guo K, Gao D, Liu Y, Ye S, Ren Z.

Ann Surg Oncol. 2012 Jul;19 Suppl 3:S375-84. doi: 10.1245/s10434-011-1836-7. Epub 2011 Jun 17.

PMID:
21681378
20.

Combination of osteopontin with peritumoral infiltrating macrophages is associated with poor prognosis of early-stage hepatocellular carcinoma after curative resection.

Zhu W, Guo L, Zhang B, Lou L, Lin Z, Zhu X, Ren N, Dong Q, Ye Q, Qin L.

Ann Surg Oncol. 2014 Apr;21(4):1304-13. doi: 10.1245/s10434-013-3445-0. Epub 2013 Dec 24.

PMID:
24366422

Supplemental Content

Support Center